Fluoroshield™ with 1,4-Diazabicyclo[2.2.2]octane is an aqueous mounting medium for preserving the fluorescence of tissue and cell smears.
Anwendung
Fluoroshield™ with 1,4-Diazabicyclo[2.2.2]octane prevents rapid photobleaching of FITC, Texas Red®, AMCA, ALEXA FLUOR™ 488, ALEXA FLUOR 594, Cy® dyes, and tetramethylrhodamine.
Prinzip
Fluoroshield™ with 1,4-Diazabicyclo[2.2.2]octane mounting medium is fortified with 1,4-Diazabicyclo[2.2.2]octane (a generic version of DABCO®), an anti-fade reagent used to retard photobleaching of fluorescein and other fluorescent dyes.
Rechtliche Hinweise
ALEXA FLUOR is a trademark of Life Technologies
Cy is a registered trademark of Cytiva
DABCO is a registered trademark of Air Products & Chemicals, Inc.
FluoroShield is a trademark of ImmunoBioScience Corp.
Texas Red is a registered trademark of Life Technologies
Developmental dynamics : an official publication of the American Association of Anatomists, 248(2), 189-196 (2018-12-21)
Among vertebrates, salamanders are unparalleled in their ability to regenerate appendages throughput life. However, little is known about early signals that initiate regeneration in salamanders. Ambystoma mexicanum embryos were administered tail amputations to investigate the timing of reactive oxygen species
IEEE journal of translational engineering in health and medicine, 8, 4100113-4100113 (2020-01-31)
Objective: investigation of the extra-low-frequency (ELF) stimulation effect on blood-cell proteins, that causes variation in its electrostatic-state. A hypothesis that this results in the conformational change in the blood-cell proteins which could enhance immune activity is explored. Since HIV-1 and
Morphological changes of cortical and hippocampal neurons after treatment with VEGF and bevacizumab.
Amyotrophic lateral sclerosis (ALS) is a common degenerative disease of the central nervous system concerning a progressive loss of upper and lower motor neurons. While 5%-10% of patients are diagnosed with the inherited form of the disease, the vast majority
A significant proportion of the more than 50 million people worldwide currently suffering with epilepsy are resistant to antiepileptic drugs (AEDs). As an alternative to AEDs, novel therapies based on cell transplantation offer an opportunity for long-lasting modification of epileptic
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..